Top compounds associated with response to DTD2


Feature Type Standardized
Nominal ANOVA
mRNA MLN2238 CTRPv2 pan-cancer AAC -0.071 0.04
mRNA BRD-K55116708 CTRPv2 pan-cancer AAC -0.076 0.04
mRNA YK 4-279 CTRPv2 pan-cancer AAC -0.066 0.04
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.073 0.04
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.064 0.05
mRNA MS-275 CTRPv2 pan-cancer AAC -0.066 0.05
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC 0.077 0.05
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC -0.063 0.05
mRNA piperlongumine CTRPv2 pan-cancer AAC -0.064 0.05
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.068 0.06
Download CSV